- Recalling firm
- Medline Industries, LP
- Reason for recall
- The kits contain neurological sponges with the potential for unexpected variability of endotoxin levels. Potentially elevated endotoxin levels may present health risks that could require medical intervention, such as neurovascular adverse events, febrile response, and/or local transient inflammation, hypotension, or nausea.
- Affected products (lot / model / serial)
- 1) DYNJ39218I, UDI-DI: 10195327013042(each), 40195327013043(case), Lot Number: 22HMA400; 2) DYNJ41246F, UDI-DI: 10195327112011(each), 40195327112012(case), Lot Number: 23GBS783; 3) DYNJ47487A, UDI-DI: 10889942106240(each), 40889942106241(case), Lot Number: 22HMD080; 4) DYNJ57233J, UDI-DI: 10198459723025(each), 40198459723026(case), Lot Number: 26CMG313; 5) DYNJ82388A, UDI-DI: 10195327482749(each), 40195327482740(case), Lot Number: 25KMB622; 6) DYNJ86656, UDI-DI: 10195327663155(each), 40195327663156(case), Lot Number: 24EDB134; 7) DYNJ904549G, UDI-DI: 10193489832686(each), 40193489832687(case), Lot Number: 23IBL172
- Units affected
- 234 kits
- Distribution pattern
- US Nationwide.
- Firm location
- Northfield, IL, United States
- Recall type
- Voluntary: Firm initiated
- How the firm notified customers
- Letter
- Product type
- Devices
- Status
- Ongoing
- Recall number
- Z-3268-2026
- Recall initiated
- August 10, 2026
- FDA classification date
- September 24, 2026
- FDA report date
- September 30, 2026
- FDA event ID
- 99739
- Last updated on HTM Vibe
- October 6, 2026
